Navigation Links
Microban Medical Silver Antimicrobial Technologies for HCR Silicone Achieve 5 Log Reductions in Bacteria Growth and Prevent Biofilm Formation

CHARLOTTE, N.C., Sept. 13, 2011 /PRNewswire/ -- Microban recently conducted in vitro testing designed to simulate planktonic and biofilm growth on High Consistency Rubber (HCR) silicone, which is commonly used in the manufacture of urinary catheters.  Urinary infections are a costly source of Hospital Acquired Infections (HAIs) and current technologies have had limited success in reducing infection rates. The new Microban® silver antimicrobial technology developed for HCR silicone by Microban Medical is engineered to meet stricter FDA guidelines. The FDA guidelines are aimed at encouraging manufacturers to adopt tougher efficacy requirements that will better correlate with decreases in patient infection rates.

Initial results for Microban® antimicrobial silver technology exceed FDA guidelines, showing greater than 5 log reductions in Proteus vulgaris, Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli versus unprotected HCR silicone. In addition, Microban microbiologists assessed the impact of Microban silver technology on biofilm formation.  "The ability of antimicrobial technologies to reduce biofilm formation is critical to reducing infection rates.  Biofilms are communities of bacteria that are capable of resisting antibiotic treatment and are more likely to cause recurrent infections," according to Gina Sloan, Ph.D. and Director of Microbiology at Microban. The results of the new study demonstrate that Microban silver antimicrobial technology is not only effective against planktonic bacteria, but importantly the technology also prevents the formation of biofilm on HCR silicone.  

"We're very excited about the in vitro study results, Microban antimicrobial silver technology will help medical device manufacturers who are utilizing HCR silicone to meet tougher FDA standards for antimicrobials in medical devices," said Ivan Ong, Ph.D. and VP of Research & Development, "and we believe this technology will also help address the growing problem of HAIs."  Microban Medical is leveraging decades of experience in polymer engineering and microbiology to create new technologies that can significantly improve the antimicrobial performance of medical devices currently available on the market.  Microban provides comprehensive development support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance.  

For detailed in vitro study results on Microban silver antimicrobial technology for HCR silicone please visit

Microban International, Ltd.

Microban International, Ltd. is a global antimicrobial solution company utilizing a broad range of antimicrobial technologies to provide safe, durable and effective antimicrobial protection.  Microban International is headquartered in North Carolina with operations in North America, Europe and Asia. For more information on Microban, please contact (704) 875-0806 or visit

CONTACT: Kathy Hall, +1-704-766-1040,

SOURCE Microban International, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology
2. Microban Partners With to Launch Yoga Mats With Zinc Antimicrobial Technology
3. Saladax Biomedical, Inc. to Present at the Annual UBS Global Life Sciences Conference in New York City
4. 2011 Lasker Awards Honor Medical Research Pioneers
5. HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College
6. The Hanover Expands Innovative Solution for the Durable Medical Equipment, Orthotics and Prosthetics Market
7. Jeunesse Global Announces New Medical Advisory Board Member and Admittance Into the Direct Selling Association (DSA).
8. MBC has the Highest Number of Medical Billers and Coders in Dallas, Texas Servicing Primary Healthcare Physicians
9. Society of Interventional Radiology Foundation Funds Howard Hughes Medical Institute Award
10. Society of Interventional Radiology Foundation Welcomes Corporate Gift From Sirtex Medical
11. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/24/2015)... 24, 2015  Asia-Pacific (APAC) holds the third-largest ... market. The trend of outsourcing to low-cost locations ... higher volume share for the region in the ... margins in the CRO industry will improve. ... ( ), finds that the market earned ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... metabolism. But unless it is bound to proteins, copper is also toxic to ... researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper ...
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions leader SAP and ... to develop and pitch their BIG ideas to improve health and wellness in their ... votes to win the title of SAP's Teen Innovator, an all-expenses paid trip to ...
Breaking Biology Technology:
(Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
(Date:11/4/2015)... --> --> ... Transparency Market Research "Home Security Solutions Market - Global Industry ... 2022", the global home security solutions market is expected to reach ... market is estimated to expand at a CAGR of ... Rising security needs among customers at homes, the emergence ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):